Table: Phoenixbio -2015/16 group results

PhoenixBio

13/05/2016 07:10

May 13 (Reuters)-  
          Phoenixbio Co., Ltd.  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales             1.22           881 mln         1.42        672 mln    
                 (+38.1 pct)     (-23.6 pct)    (+16.9 pct)  (+38.7 pct)  
  Operating        190 mln         50 mln         354 mln      123 mln    
                (+275.6 pct)     (-11.4 pct)    (+86.5 pct)               
  Recurring        149 mln         62 mln         347 mln      115 mln    
                (+138.1 pct)     (+23.0 pct)   (+132.6 pct)               
  Net 
  Net              125 mln         56 mln         299 mln       98 mln    
                (+120.7 pct)     (-55.8 pct)   (+138.9 pct)               
  EPS             49.32 yen       22.72 yen     103.62 yen    34.26 yen   
  EPS Diluted     48.42 yen                                               
  Ann Div            NIL             NIL            NIL                   
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div            NIL             NIL            NIL                   
   
  NOTE - Phoenixbio Co., Ltd.. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T 
  ((Tokyo Headline News Desk +813 6441 1812))